文献速递慢病管理

荷兰慢性疾病负担评估量表(ABCC)在COPD、哮喘和2型糖尿病中的效度与信度研究

Validity and Reliability of the Assessment of Burden of Chronic Conditions Scale in the Netherlands.
PubMed 文献 · Ann Fam Med · 2023-01-01

本研究评估ABCC量表在COPD、哮喘或2型糖尿病患者中的效度与信度。共纳入65例COPD、62例哮喘和60例2型糖尿病患者,通过与SGRQ、AQLQ-S和ADDQoL19比较评估聚合效度,用Cronbach's α评估内部一致性,间隔2周评估重测信度。结果显示ABCC量表具有良好效度和信度,可用于上述人群的临床评估。

要点

  • ABCC量表在COPD、哮喘和2型糖尿病患者中显示良好聚合效度,与各疾病特异性生活质量问卷的相关性符合预期假设。
  • ABCC量表内部一致性高,COPD、哮喘和2型糖尿病总分的Cronbach's α分别为0.90、0.92和0.91。
  • ABCC量表重测信度良好,COPD、哮喘和2型糖尿病的组内相关系数分别为0.95、0.93和0.95。

核心结论

  • ABCC量表是有效且可靠的问卷,可用于COPD、哮喘或2型糖尿病患者的评估。
  • 未来研究需明确该量表是否适用于多病共存人群,以及临床使用中的效果和体验。

研究设计与样本

  • 本研究为效度与信度评价研究,比较ABCC量表与SGRQ、AQLQ-S和ADDQoL19以评估聚合效度。
  • 纳入65例COPD、62例哮喘和60例2型糖尿病患者,用Cronbach's α评估内部一致性,间隔2周评估重测信度。

主要发现

  • ABCC量表与SGRQ的相关性在75%的假设中≥0.7,与AQLQ-S的相关性100%符合假设,与ADDQoL19的相关性75%符合假设。
  • COPD、哮喘和2型糖尿病患者的ABCC总分Cronbach's α分别为0.90、0.92和0.91。
  • COPD、哮喘和2型糖尿病患者的组内相关系数分别为0.95、0.93和0.95。

关键数值与推荐

  • 聚合效度:ABCC与SGRQ相关性75%≥0.7,与AQLQ-S相关性100%符合假设,与ADDQoL19相关性75%符合假设。
  • 内部一致性:COPD、哮喘、2型糖尿病总分的Cronbach's α分别为0.90、0.92、0.91。
  • 重测信度:COPD、哮喘、2型糖尿病的组内相关系数分别为0.95、0.93、0.95(间隔2周)。

临床怎么用

  • 全科医生可使用ABCC量表评估COPD、哮喘或2型糖尿病患者的疾病负担,促进共享决策和自我管理。
  • ABCC量表可将患者体验到的慢性疾病负担可视化并整合到日常诊疗中。

局限性

  • 研究未纳入多病共存人群,ABCC量表在该人群中的效度和信度尚不明确。
  • 临床使用中的效果和患者体验尚未评估,需未来研究进一步明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The Assessment of Burden of Chronic Conditions (ABCC) tool was developed to improve care by facilitating shared decision making and self-management. It assesses and visualizes the experienced burden of 1 or multiple chronic conditions and integrates it in daily care. The aim of this study is to evaluate whether the ABCC scale is valid and reliable in people with chronic obstructive pulmonary disease (COPD), asthma, or type 2 diabetes (T2D). METHODS: The Saint George Respiratory Questionnaire (SGRQ), the Standardized Asthma Quality of Life Questionnaire (AQLQ-S), and the Audit of Diabetes Dependent Quality of Life Questionnaire (ADDQoL19) were compared with the ABCC scale to assess convergent validity. The internal consistency was evaluated using Cronbach's α. Test-retest reliability was evaluated at a 2-week interval. RESULTS: A total of 65 people with COPD, 62 with asthma, and 60 with T2D were included. The ABCC scale correlated, in accordance with hypotheses, with the SGRQ (75% of correlations ≥0.7), AQLQ-S (100%), and ADDQoL19 (75%). The ABCC scale was internally consistent with a Cronbach's α of 0.90, 0.92, and 0.91 for the total score for people with COPD, asthma, and T2D, respectively. The ABCC scale had a good test-retest reliability with an intraclass correlation coefficient of 0.95, 0.93, and 0.95 for people with COPD, asthma, and T2D, respectively. CONCLUSIONS: The ABCC scale is a valid and reliable questionnaire that can be used within the ABCC tool for people with COPD, asthma, or T2D. Future research should indicate whether this applies to people with multimorbidity, and what the effects and experiences are upon clinical use.

来源:Ann Fam Med,查看原文。版权归原作者所有。

引用

  1. Claessens D, Boudewijns EA, Keijsers LCEM, et al. Validity and Reliability of the Assessment of Burden of Chronic Conditions Scale in the Netherlands. Ann Fam Med. 2023. PMID: 36973066. doi:10.1370/afm.2954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。